NasdaqGS - Delayed Quote USD

Design Therapeutics, Inc. (DSGN)

3.6500 -0.0100 (-0.27%)
At close: April 24 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
78,190.0000
78,190.0000
67,593.0000
35,831.0000
8,330.0000
Operating Income
-78,190.0000
-78,190.0000
-67,593.0000
-35,831.0000
-8,330.0000
Other Income Expense
11,328.0000
11,328.0000
4,285.0000
298.0000
50.0000
Pretax Income
-66,862.0000
-66,862.0000
-63,308.0000
-35,533.0000
-8,280.0000
Net Income Common Stockholders
-66,862.0000
-66,862.0000
-63,308.0000
-35,533.0000
-8,280.0000
Diluted NI Available to Com Stockholders
-66,862.0000
-66,862.0000
-63,308.0000
-35,533.0000
-8,280.0000
Basic EPS
-1.19
--
-1.14
-0.77
-0.15
Diluted EPS
-1.19
--
-1.14
-0.77
-0.15
Basic Average Shares
55,984.6700
--
55,707.5170
45,936.2350
53,817.3220
Diluted Average Shares
55,984.6700
--
55,707.5170
45,936.2350
53,817.3220
Total Operating Income as Reported
-78,190.0000
-78,190.0000
-67,593.0000
-35,831.0000
-8,330.0000
Total Expenses
78,190.0000
78,190.0000
67,593.0000
35,831.0000
8,330.0000
Net Income from Continuing & Discontinued Operation
-66,862.0000
-66,862.0000
-63,308.0000
-35,533.0000
-8,280.0000
Normalized Income
-66,862.0000
-66,862.0000
-63,308.0000
-35,533.0000
-8,280.0000
EBIT
-78,190.0000
-78,190.0000
-67,593.0000
-35,831.0000
-8,330.0000
EBITDA
-77,653.0000
-77,653.0000
-67,187.0000
-35,702.0000
-8,325.0000
Reconciled Depreciation
537.0000
537.0000
406.0000
129.0000
5.0000
Net Income from Continuing Operation Net Minority Interest
-66,862.0000
-66,862.0000
-63,308.0000
-35,533.0000
-8,280.0000
Normalized EBITDA
-77,653.0000
-77,653.0000
-67,187.0000
-35,702.0000
-8,325.0000
12/31/2020 - 3/29/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IKNA Ikena Oncology, Inc.
1.2900
-4.44%
 
GLUE Monte Rosa Therapeutics, Inc.
5.47
-1.26%
 
TYRA Tyra Biosciences, Inc.
16.00
-2.32%
 
EWTX Edgewise Therapeutics, Inc.
16.11
+2.94%
 
CGEM Cullinan Therapeutics, Inc.
18.89
+13.32%
 
VOR Vor Biopharma Inc.
1.7400
-7.45%
 
GHRS GH Research PLC
11.08
-1.95%
 
LYEL Lyell Immunopharma, Inc.
2.3000
-5.74%
 
BRNS Barinthus Biotherapeutics plc
2.5100
-3.46%
 
IMRX Immuneering Corporation
1.5000
-7.98%